121 related articles for article (PubMed ID: 6200112)
1. Biochemical correlates of phenotypic reversion in interferon-treated mouse cells transformed by a human oncogene.
Samid D; Chang EH; Friedman RM
Biochem Biophys Res Commun; 1984 Feb; 119(1):21-8. PubMed ID: 6200112
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional inhibition of Ha-ras in interferon-induced revertants of ras-transformed mouse cells.
Rimoldi D; Samid D; Flessate DM; Friedman RM
Cancer Res; 1988 Sep; 48(18):5157-62. PubMed ID: 2457435
[TBL] [Abstract][Full Text] [Related]
3. Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidine.
Samid D; Flessate DM; Friedman RM
Mol Cell Biol; 1987 Jun; 7(6):2196-200. PubMed ID: 2439904
[TBL] [Abstract][Full Text] [Related]
4. Biological and morphological characteristics of phenotypic revertants appearing in interferon-treated mouse cells transformed by a human oncogene.
Samid D; Chang EH; Friedman RM; Schaff Z; Greene JJ
J Exp Pathol; 1985; 2(3):211-22. PubMed ID: 2431116
[TBL] [Abstract][Full Text] [Related]
5. Interferon-induced modulation of human ras oncogene expression.
Samid D; Schaff Z; Chang EH; Friedman RM
Prog Clin Biol Res; 1985; 192():265-8. PubMed ID: 2417251
[TBL] [Abstract][Full Text] [Related]
6. Resistance to oncogenic transformation in revertant R1 of human ras-transformed NIH 3T3 cells.
Kuzumaki N; Ogiso Y; Oda A; Fujita H; Suzuki H; Sato C; Müllauer L
Mol Cell Biol; 1989 May; 9(5):2258-63. PubMed ID: 2664473
[TBL] [Abstract][Full Text] [Related]
7. A specific protein, p92, detected in flat revertants derived from NIH/3T3 transformed by human activated c-Ha-ras oncogene.
Fujita H; Suzuki H; Kuzumaki N; Müllauer L; Ogiso Y; Oda A; Ebisawa K; Sakurai T; Nonomura Y; Kijimoto-Ochiai S
Exp Cell Res; 1990 Jan; 186(1):115-21. PubMed ID: 2153549
[TBL] [Abstract][Full Text] [Related]
8. A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines.
Chang MY; Won SJ; Liu HS
J Cancer Res Clin Oncol; 1997; 123(2):91-9. PubMed ID: 9030247
[TBL] [Abstract][Full Text] [Related]
9. Interferons and oncogenes.
Clemens M
Nature; 1985 Feb 14-20; 313(6003):531-2. PubMed ID: 2578626
[No Abstract] [Full Text] [Related]
10. Short-term treatment with gamma interferon induces stable reversion of ras-transformed mouse fibroblasts.
Seliger B; Pfizenmaier K; Schäfer R
J Virol; 1991 Nov; 65(11):6307-11. PubMed ID: 1717721
[TBL] [Abstract][Full Text] [Related]
11. Dose effects of transfected c-Ha-rasVal 12 oncogene in transformed cell clones.
Sistonen L; Keski-Oja J; Ulmanen I; Hölttä E; Wikgren BJ; Alitalo K
Exp Cell Res; 1987 Feb; 168(2):518-30. PubMed ID: 3803452
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
13. Development of transformed phenotype induced by a human ras oncogene is inhibited by interferon.
Samid D; Chang EH; Friedman RM
Biochem Biophys Res Commun; 1985 Jan; 126(1):509-16. PubMed ID: 3970704
[TBL] [Abstract][Full Text] [Related]
14. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
[TBL] [Abstract][Full Text] [Related]
15. Transformation of normal homologous cells by a spontaneously activated Ha-ras oncogene.
Schwartz SA; Shuler CF; Freebeck P
Cancer Res; 1988 Jun; 48(12):3470-7. PubMed ID: 3285996
[TBL] [Abstract][Full Text] [Related]
16. Suppression and re-expression of transformed phenotype in hybrids of HA-ras-1-transformed rat-1 cells and early-passage rat embryonic fibroblasts.
Griegel S; Traub O; Willecke K; Schäfer R
Int J Cancer; 1986 Nov; 38(5):697-705. PubMed ID: 3533793
[TBL] [Abstract][Full Text] [Related]
17. Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein.
Stacey DW; Kung HF
Nature; 1984 Aug 9-15; 310(5977):508-11. PubMed ID: 6611509
[TBL] [Abstract][Full Text] [Related]
18. Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras.
Contente S; Kenyon K; Rimoldi D; Friedman RM
Science; 1990 Aug; 249(4970):796-8. PubMed ID: 1697103
[TBL] [Abstract][Full Text] [Related]
19. Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes.
Bradley MO; Kraynak AR; Storer RD; Gibbs JB
Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5277-81. PubMed ID: 3523488
[TBL] [Abstract][Full Text] [Related]
20. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
